ELAINE STONE, M.D.; BERNARD ZINMAN, M.D.
To the editor: The synthetic vasopressin analogue 1-deamino-8-D-arginine (dDAVP) has been recommended as the preferred form of treatment for neurogenic diabetes insipidus (1). It has the characteristics of increased antidiuretic activity and decreased pressor activity and results in good control of symptoms as compared to previously used preparations (2). Noteworthy side effects of dDAVP have been few. As stated in a recent review (3), water intoxication and hyponatremia have not been reported to occur in outpatients presumably because the state of hydration affects the metabolic clearance of dDAVP (4). We report here that dDAVP is subject to drug abuse and
Learn more about subscription options.
Register Now for a free account.
STONE E, ZINMAN B. Hyponatremia from 1-Deamino-8-d-Arginine (dDAVP) Abuse. Ann Intern Med. 1980;92:711. doi: 10.7326/0003-4819-92-5-711_1
Download citation file:
Published: Ann Intern Med. 1980;92(5):711.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only